{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:41:59Z","timestamp":1773218519164,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.brachy.2020.11.006","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T08:33:30Z","timestamp":1611045210000},"page":"368-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Toxicity and outcomes associated with high-dose rate brachytherapy for medically inoperable endometrial cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Alexander","family":"Yaney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Wald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueliang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Quick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2020.11.006_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2020.11.006_bib2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.AOG.0000462977.61229.de","article-title":"Endometrial cancer","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2020.11.006_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.6004\/jnccn.2009.0035","article-title":"Uterine neoplasms","volume":"7","author":"Greer","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.brachy.2020.11.006_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0360-3016(93)90201-6","article-title":"Exclusive radiation therapy in endometrial carcinoma","volume":"26","author":"Rouanet","year":"1993","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/gyno.1996.0123","article-title":"Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma of the endometrium","volume":"61","author":"Fishman","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.brachy.2008.11.006","article-title":"The management of inoperable Stage I endometrial cancer using intracavitary brachytherapy alone: a 20-year institutional review","volume":"8","author":"Shenfield","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib7","first-page":"1008","article-title":"Treatment of endometrial carcinoma with high-dose-rate brachytherapy alone in medically inoperable stage I patients","volume":"77","author":"Kucera","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.brachy.2020.11.006_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/gyno.1995.9960","article-title":"High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I\u2013II endometrial carcinoma","volume":"59","author":"Nguyen","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejca.2016.07.005","article-title":"Systemic review: radiation therapy alone in medical non-operable endometrial carcinoma","volume":"65","author":"van der Steen-Banasik","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2020.11.006_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0360-3016(00)00689-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.brachy.2015.06.002","article-title":"Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer","volume":"14","author":"Schwarz","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijrobp.2007.10.026","article-title":"High-dose-rate Rotte \u201cY\u201d applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results","volume":"71","author":"Coon","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejmp.2017.11.007","article-title":"Comparison of different treatment planning optimization methods for vaginal HDR brachytherapy with multichannel applicators: a reduction of the high doses to the vaginal mucosa is possible","volume":"44","author":"Carrara","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.brachy.2020.11.006_bib14","article-title":"Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: a single-institution study","author":"Umezawa","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib15","doi-asserted-by":"crossref","first-page":"20140018","DOI":"10.1259\/bjr.20140018","article-title":"Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer","volume":"87","author":"Dankulchai","year":"2014","journal-title":"BJR"},{"key":"10.1016\/j.brachy.2020.11.006_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brachy.2016.10.004","article-title":"Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy","volume":"16","author":"Kauffmann","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ygyno.2017.09.006","article-title":"Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma","volume":"147","author":"Gebhardt","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.brachy.2017.08.006","article-title":"Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma","volume":"16","author":"Jordan","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0360-3016(88)90195-2","article-title":"Radiation therapy alone for medically inoperable patients with adenocarcinoma of the endometrium","volume":"15","author":"Taghian","year":"1988","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0360-3016(96)00486-5","article-title":"Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients","volume":"37","author":"Knocke","year":"1997","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.1998.5148","article-title":"High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer","volume":"71","author":"Nguyen","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1269\/jrr.10080","article-title":"Long-term results of high-dose-rate brachytherapy and external-beam radiotherapy in the primary treatment of endometrial cancer","volume":"51","author":"Inciura","year":"2010","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.brachy.2020.11.006_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1269\/jrr.11024","article-title":"Dose volume Analysis of radiotherapy for inoperable patients with stage I\u2013II endometrial carcinoma","volume":"52","author":"Ohkubo","year":"2011","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.brachy.2020.11.006_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.brachy.2019.03.005","article-title":"Magnetic resonance imaging response in patients treated with definitive radiation therapy for medically inoperable endometrial cancer\u2014does it predict treatment response?","volume":"18","author":"Gebhardt","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5114\/jcb.2017.67454","article-title":"Definitive three-dimensional high-dose-rate brachytherapy for inoperable endometrial cancer","volume":"9","author":"Draghini","year":"2017","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2015.12.019","article-title":"Medically inoperable endometrial cancer in patients with a high body mass index (BMI): patterns of failure after 3-D image-based high dose rate (HDR) brachytherapy","volume":"118","author":"Acharya","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib27","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ijrobp.2005.04.036","article-title":"Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I\u2013II endometrial carcinoma","volume":"63","author":"Niazi","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.11.006_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.brachy.2014.07.002","article-title":"Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma","volume":"13","author":"Gill","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brachy.2020.01.003","article-title":"Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer","volume":"19","author":"Gannavarapu","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2020.05.032","article-title":"Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients","volume":"158","author":"Espenel","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2011.09.022","article-title":"Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma","volume":"124","author":"Podzielinski","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2020.11.006_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.brachy.2014.03.001","article-title":"3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes","volume":"13","author":"Kharofa","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.11.006_bib33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.brachy.2013.09.005","article-title":"The dosimetric impact of single, dual, and triple tandem applicators in the treatment of intact uterine cancer","volume":"13","author":"Johnson","year":"2014","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120302506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472120302506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:15:39Z","timestamp":1761531339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472120302506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1538472120302506"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2020.11.006","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity and outcomes associated with high-dose rate brachytherapy for medically inoperable endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2020.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}